Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Pens Distribution Deal with Kreatech

NEW YORK, Oct. 10 – Qiagen said on Wednesday that it has received an exclusive license to market and distribute Kreatech Biotechnology’s ULS labeling technologies in combination with its resonance light scattering products.

In addition, Qiagen acquired non-exclusive rights to develop and sell ULS products for labeling and detecting nucleic acids and proteins in microarray experiments.

Qiagen, of Venlo, the Netherlands, said it would market these products with its nucleic acid sample separation and purification products and biomolecule detection technologies. The company also said that it would work with Kreatech to develop new applications and specialized products.

Qiagen did not disclose the financial terms of the deal.

Kreatech, based in Amsterdam, develops diagnostics and other life-science products.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.